Randomized Phase II Study of Gemcitabine with or Without ATR Inhibitor Berzosertib in Platinum-Resistant Ovarian Cancer: Final Overall Survival and Biomarker AnalysesPanagiotis A. Konstantinopoulos,Su-Chun Cheng,Elizabeth K. Lee,Alexandre Andre B. A. da Costa,Doga Gulhan,Andrea E. Wahner Hendrickson,Bose Kochupurakkal,David L. Kolin,Elise C. Kohn,Joyce F. Liu, Richard T. Penson,Elizabeth H. Stover,Jennifer Curtis,Hannah Sawyer,Madeline Polak,Dipanjan Chowdhury,Alan D. D'Andrea,Anniina Farkkila,Geoffrey I. Shapiro,Ursula A. MatulonisJournal of Clinical Oncology（2023）引用 1|浏览51暂无评分关键词Tumor SuppressorAI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
